The aim of the study was to assess the frequency of SEPT9 promoter methylation in patients with various pathological types and stages of lung cancer, as well as a pilot evaluation of usefulness of this marker in early diagnostic of the disease. This evidence concerns the gene SEPTIN9 and lung cancer.